Brevet Année : 2023

Composition comprising a lasso peptide formulated in a pharmaceutically acceptable nanoemulsion

Résumé

The present invention relates to a composition comprising a lasso peptide formulated in a pharmaceutically acceptable nanoemulsion and an antibiotic, to said composition for use as a medicine, and to a method for producing said composition. The composition of the present invention finds an application for example for the treatment of an infection by a Gram-positive bacterium.

Fichier non déposé

Dates et versions

hal-04394817 , version 1 (15-01-2024)

Identifiants

  • HAL Id : hal-04394817 , version 1

Citer

Caroline Giraud, Yanyan Li, Christophe Goulard, Axel Hartke, Abdelhakim Boudrioua, et al.. Composition comprising a lasso peptide formulated in a pharmaceutically acceptable nanoemulsion. France, Patent n° : EP23306748.7. 2023. ⟨hal-04394817⟩
171 Consultations
0 Téléchargements

Partager

  • More